G. Jones

发表

Flexible palladium-catalysed amidation reactions for the synthesis of complex aryl amides

S. Dabbs, D. Davies, R. Markwell, 2010 .

Novel tricyclics (e.g., GSK945237) as potent inhibitors of bacterial type IIA topoisomerases.

S. Dabbs, D. Davies, E. Minthorn, 2016, Bioorganic & medicinal chemistry letters.

Novel hydroxyl tricyclics (e.g., GSK966587) as potent inhibitors of bacterial type IIA topoisomerases.

S. Dabbs, D. Davies, E. Minthorn, 2013, Bioorganic & medicinal chemistry letters.

Novel cyclohexyl-amides as potent antibacterials targeting bacterial type IIA topoisomerases.

S. Dabbs, D. Davies, Susanne Eyrisch, 2011, Bioorganic & medicinal chemistry letters.

Novel amino-piperidines as potent antibacterials targeting bacterial type IIA topoisomerases.

S. Dabbs, D. Davies, T. Gallagher, 2011, Bioorganic & medicinal chemistry letters.

Synthesis of 4-alkyl-1-trimethylsilylbuta-1,3-diynes

A. Holmes, G. Jones, 1980 .

1,4‐Bis(trimethylsilyl)buta‐1,3‐diyne

A. Holmes, G. Jones, D. Kendrick, 2003 .

Acylation reactions of silylated butadiynes: synthesis of some naturally occuring diacetylenic ketones

A. Holmes, G. Jones, 1982 .

The design of efficient and selective routes to a key 1,4-cis-substituted cyclohexylamide intermediate

D. Davies, M. McGuire, R. Markwell, 2010 .

The Rational Design of Selective Benzoxazepin Inhibitors of the α-Isoform of Phosphoinositide 3-Kinase Culminating in the Identification of (S)-2-((2-(1-Isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)oxy)propanamide (GDC-0326).

S. Steinbacher, Steve Price, E. Gancia, 2016, Journal of medicinal chemistry.

The action of diethylaminosulphur trifluoride (dast) on trans-4-amido- 3-Chromanols: Preparation of cis-amidoalcohols via oxazolines

G. Stemp, G. Jones, John M. Evans, 1990 .

Discovery of thiazolobenzoxepin PI3-kinase inhibitors that spare the PI3-kinase β isoform.

Steve Price, M. Belvin, BinQing Wei, 2013, Bioorganic & medicinal chemistry letters.

N-(1-methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl)urea: a novel, high-affinity 5-HT2B receptor antagonist.

I. Forbes, G. E. Jones, V. Holland, 1995, Journal of medicinal chemistry.

Structure-Based Exploration of Selectivity for ATM Inhibitors in Huntington's Disease.

M. Lamers, R. Cachope, G. Mcallister, 2021, Journal of medicinal chemistry.